Video description: 2026 NMN vs NR trials, dosing, safety and supplement quality
The description says two 2026 human trials compared NMN and NR: in one, the NMN arm was stopped early because NR raised blood NAD+ 2.3 times more effectively, while a second trial found them essentially tied. It also promises coverage of doses, safety, a cancer warning, label-testing failures and whether raising NAD+ extends lifespan. [1]
Automatic summary · not editorially reviewed
The key findings
The description says one 2026 human trial stopped its NMN arm early because NR was 2.3 times more effective at raising blood NAD+. [1]
The description says a second 2026 trial found NMN and NR essentially tied. [1]
The description says the video covers doses, safety, a cancer warning, label-testing failures and whether raising NAD+ extends lifespan. [1]
The source at a glance
- Study type / format
- Video description announcing a discussion of two 2026 human trials
- Population / context
- People described as taking NMN or NR NAD+ precursor supplements; trial participants are not described.
- Summary based on
- Creator description
- Original publication
- May 2, 2026
Two 2026 trials with conflicting NMN vs NR results
According to the description, two major human trials published in 2026 compared NMN and NR, the two most popular NAD+ precursor supplements. In one study, researchers stopped the NMN arm early because NR was 2.3 times more effective at raising blood NAD+. A second trial found the two essentially tied. The description names the Bergen iScience trial and the Nestlé Research study as the studies discussed. It presents these as head-to-head clinical results, but gives no participant numbers, doses or follow-up times.
Supporting source [1]
Doses, safety, cancer warning and supplement quality promised
The description says the video covers effective doses, safety considerations, a cancer warning, drug interactions and who should avoid NAD+ precursors. It also says most NMN brands on Amazon fail label testing and promises guidance on buying smart. It further says the video asks whether intravenous NAD+ drips are worth the money. None of these details are given in the description itself; they are only announced as topics.
Supporting source [1]
Open question: lifespan or only biomarkers?
The description says the video raises what it calls the bigger question nobody in the longevity space wants to ask: does raising NAD+ actually extend lifespan or just change biomarkers? It also says the video explains why NMN gets converted to NR in the body. The description does not report any lifespan result, so the question remains open here.
Supporting source [1]
How to interpret this
Only the video description was available; the video and transcript were not reviewed. All details come from the creator's description, which gives no participant numbers, doses, follow-up times or full results. The cancer warning and label-testing claim are announced topics, not substantiated in the description.
Based on the creator’s description; the full video and transcript were not analyzed.
Source & supporting passages
Vegetablah · youtube.com · May 2, 2026